Statistics

Total Visits

Views
Tenofovir for the prophylaxis of HBV reactivation in anti-HBC-positive patients with hematologic malignancies treated with rituximab: Preliminary results of a randomized study (preblin study)41

Select a period of time:

Number of views in the range

Views
Tenofovir for the prophylaxis of HBV reactivation in anti-HBC-positive patients with hematologic malignancies treated with rituximab: Preliminary results of a randomized study (preblin study)24

Views

Views
March 202515
April 20252
May 20250
June 20250
July 20256
August 20251
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States4
Brazil3
Spain1
Kenya1
 

Top cities views

Views
Council Bluffs1
Dallas1
Ellabell1
Goiânia1
Nairobi1
Petrópolis1
Quipapá1